Movetis Seeking up to 112.4 Million Euros in IPO  
11/20/2009 7:37:06 AM

Bookmark and Share

Reuters -- Belgian drugmaker Movetis said it could raise up to 112.4 million euros ($167 million) in an initial public offering to help fund the European launch of its Resolor treatment for chronic constipation in women.